Immunotherapy Drugs Market

Immunotherapy Drugs Market - Global
Industry Analysis, Size, Share, Growth,
Trends and Forecast 2016 - 2024
Transparency Market Research Reports incorporated a definite
business overview and investigation inclines on
"Immunotherapy Drugs Market". This report likewise
incorporates more illumination about fundamental review of the
business including definitions, requisitions and worldwide
business sector industry structure.
Traditionally, the basis of cancer treatment is comprised of
radiation therapy, surgery, and chemotherapy. Recently, many
positive treatment options have emerged in the field of immunooncology.
These next generation cancer treatment options point
to the opportunity of new improved techniques of anticancer
therapy. Immunotherapy is termed as a biological therapy in
which the primary aim is to improve the human immunity
system to fight against diseases such as cancer and infectious
diseases. Immunotherapy treatment increases the overall
immunity of the body and confines the growth of cancer cells.
The treatment allows immune cells to kill cancer cells from the
body.
The global immunotherapy drugs market is driven by the rising
incidences of cancer. The major factor for most cancers is the
rise in geriatric population, as cancer rates increase with age.

According to a report from WHO in 2015, approximately 50%
of people treated with cancer in the U.K. are over the age of 60.
Obesity, change in lifestyle, smoking, and eating habits are other
important factors which are increasing the number of cancer
patients. People are favoring toward cancer treatments with
lesser side effects. This factor is likely to propel the growth of
the global immunotherapy drugs market in the next few years, as
immunotherapy drugs are found to have lesser side effects as
compared to other treatments.
Browse Full Research Report on Immunotherapy Drugs
Market:
http://www.transparencymarketresearch.com/immunotherapy-drugsmarket.html
Rise in opportunities in developing markets and immunotherapy
as a substitute to chemotherapy for first line treatment are
drivers which are expected to propel the growth of the market.
In addition, quicker drug approval process and high prevalence
rate of lifestyle diseases are projected to drive the market growth
during the forecast period. However, high cost of
immunotherapy devices, overall costly treatments, and lack of
awareness about immunotherapy drugs and techniques are
estimated to restrain the growth of the global immunotherapy
drugs market in the near future.

The global immunotherapy drugs market is classified on the
basis of type of drugs, application, end-user, and region. On the
basis of type of drugs, the market is segmented into checkpoint
inhibitors, adult vaccines, interleukins, monoclonal antibodies,
interferons, alpha and beta, and others. The adult vaccines
segment is subsegmented into therapeutic vaccines and
preventive vaccines.
The development of novel drugs and the entry of new molecules
such as elotuzumab, obinutuzumab, zanolimumab, and
onartuzumab into the market are projected to support the growth
of this segment. On the basis of application, the market is
classified as autoimmune and inflammatory diseases, cancer,
infectious diseases, and others. The cancer segment is
anticipated to hold a large part of the market share during the
forecast period.
Geographically, the global immunotherapy drugs market is
distributed over North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America is expected
to dominate the market during the forecast period due to
favorable government initiatives, healthy R&D investment,
personalized medicine, development of next generation
sequencing, and availability of technologically advanced health
care research framework.

According to a report by WHO in 2016, it is anticipated that
1.75 million new cancer patients are likely to be detected in the
U.S. only. Asia Pacific is estimated to register a high growth
rate of the immunotherapy drugs market in the next few years
due to development of health care infrastructure, high disposable
income, rise in health and hygiene related awareness, large
untapped market base, and economic development.
Key players operating in the global immunotherapy drugs
market include GE Healthcare; Thermo Fisher Scientific Inc.;
Cepheid; F. Hoffmann-La Roche Ltd; OPKO Health, Inc.;
Myriad Genetics, Inc.; Agilent Technologies; Koninklijke
Philips N.V; Qiagen; Illumina, Inc.; Novartis AG; Abbott;
PerkinElmer, Inc.; Genomic Health, Inc.; and Sysmex
Corporation.
About Us
Transparency Market Research (TMR) is a global market
intelligence company providing business information reports
and services. The company’s exclusive blend of quantitative
forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants use proprietary data

sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a
team of research experts so that it always reflects the latest
trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous
primary and secondary research techniques to develop
distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com